HMOX1 and breast cancer: Kim et al. found that targeting HO-1 using HO-1 inhibitor, zinc protophorphyrin IX (ZnPP), facilitates the conversion of TAMs into M1-like phenotype, resulting in an improvement of cytotoxic T cell functions (122) in syngeneic murine breast cancer (4T1) model.